The DOI matches its Crossref record, with a small difference in title or year; 1 of the 1 references it cites were found in a registry or an index.
Multicenter Evaluation of the BioFire FilmArray Gastrointestinal Panel for Etiologic Diagnosis of Infectious Gastroenteritis
Open accessAbstract
The appropriate treatment and control of infectious gastroenteritis depend on the ability to rapidly detect the wide range of etiologic agents associated with the disease. Clinical laboratories currently utilize an array of different methodologies to test for bacterial, parasitic, and viral causes of gastroenteritis, a strategy that suffers from poor sensitivity, potentially long turnaround times, and complicated ordering practices and workflows. Additionally, there are limited or no testing methods routinely available for most diarrheagenic Escherichia coli strains, astroviruses, and sapoviruses. This study assessed the performance of the FilmArray Gastrointestinal (GI) Panel for the simultaneous detection of 22 different enteric pathogens directly from stool specimens: Campylobacter spp., Clostridium difficile (toxin A/B), Plesiomonas shigelloides , Salmonella spp., Vibrio spp., Vibrio cholerae , Yersinia enterocolitica , enteroaggregative E. coli , enteropathogenic E. coli , enterotoxigenic E. coli , Shiga-like toxin-producing E. coli ( stx 1 and stx 2 ) (including specific detection of E. coli O157), Shigella spp./enteroinvasive E. coli , Cryptosporidium spp., Cyclospora cayetanensis , Entamoeba histolytica , Giardia lamblia , adenovirus F 40/41, astrovirus, norovirus GI/GII, rotavirus A, and sapovirus. Prospectively collected stool specimens ( n = 1,556) were evaluated using the BioFire FilmArray GI Panel and tested with conventional stool culture and molecular methods for comparison. The FilmArray GI Panel sensitivity was 100% for 12/22 targets and ≥94.5% for an additional 7/22 targets. For the remaining three targets, sensitivity could not be calculated due to the low prevalences in this study. The FilmArray GI Panel specificity was ≥97.1% for all panel targets. The FilmArray GI Panel provides a comprehensive, rapid, and streamlined alternative to conventional methods for the etiologic diagnosis of infectious gastroenteritis in the laboratory setting. The potential advantages include improved performance parameters, a more extensive menu of pathogens, and a turnaround time of as short as 1 h.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The low percentage of failures (6/1,577 [0.38%]) is consistent with other published data on different FilmArray panels and indicates there was not a significant amount of inhibition of PCR in the samples (15).”
From Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens (2016) · cites this paper as [15]
In the citing paper
“The low percentage of failures (6/1,577 [0.38%]) is consistent with other published data on different FilmArray panels and indicates there was not a significant amount of inhibition of PCR in the samples (15).”
From Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens (2016) · cites this paper as [15]
Citations
Cites
Clostridium difficile Infection in Infants and Children
COMMITTEE ON INFECTIOUS DISEASES, Schutze, G. E., Willoughby, R. E., Brady, M. T., Byington, C. L., Davies, H. D., Edwards, K. M., Glode, M. P., Jackson, M. A., Keyserling, H. L., et al. (2013) · PEDIATRICS · doi:10.1542/peds.2012-2992 · Cited by 256
Flagged first, then by citations
Research works printed but not linked: 70
- 10.1016/S0140-6736(12)60560-1 · DOI · Paper page
- 10.1097/MOP.0b013e3282f43067 · DOI
- 10.1016/S1471-4922(02)02253-5 · DOI · Paper page
- 10.3201/eid1701.P21101 · DOI
- 10.1086/526530 · DOI
- Centers for Disease Control and Prevention (CDC). 2012. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 61:157–162.
- 10.1016/j.diagmicrobio.2013.07.020 · DOI
- 10.1016/j.jhin.2014.02.011 · DOI
- 10.1056/NEJMcp031534 · DOI
- 10.1093/infdis/jis215 · DOI
- Keusch GT, Fontaine O, Bhargava A, Boschi-Pinto C, Bhutta ZA, Gotuzzo E, Rivera J, Chow J, Shahid-Salles S, Laxminarayan R. 2006. Diarrhealdiseases, p. 372. In Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P (ed), Disease control priorities in developing countries, 2nd ed. World Bank, Washington, DC.
- 10.1053/j.gastro.2009.02.072 · DOI
- 10.1128/JCM.02238-13 · DOI
- 10.1097/QCO.0b013e32834aa13a · DOI
- 10.1309/EQP21KEMBB6EHG9B · DOI
- 10.1128/JCM.02877-13 · DOI
- 10.1128/JCM.44.4.1405-1412.2006 · DOI
- 10.1128/JCM.42.3.1220-1223.2004 · DOI
- 10.1002/jmv.20699 · DOI
- 10.1093/biomet/26.4.404 · DOI
- 10.1046/j.1365-2672.1999.00474.x · DOI
- 10.1128/JCM.01124-10 · DOI
- 10.1128/JCM.01637-14 · DOI
- 10.1016/S0163-4453(86)94398-7 · DOI
- 10.1136/jcp.40.6.702-b · DOI
- 10.1128/CMR.11.3.440 · DOI
- 10.1086/514957 · DOI
- 10.1051/vetres:2005012 · DOI
- 10.1128/JCM.39.7.2713-2716.2001 · DOI
- 10.1111/1469-0691.12623 · DOI
- 10.1128/JCM.39.1.332-334.2001 · DOI
- 10.2143/ACB.3170 · DOI
- 10.3201/eid2002.121797 · DOI
- 10.1016/j.eimc.2012.04.011 · DOI
- 10.1016/j.vetpar.2010.04.028 · DOI
- 10.1099/jmm.0.034181-0 · DOI
- 10.1016/j.diagmicrobio.2011.04.002 · DOI
- 10.1016/j.jviromet.2006.12.001 · DOI
- 10.1016/j.diagmicrobio.2011.08.023 · DOI
- 10.1016/j.jcv.2013.06.022 · DOI
- 10.1128/JCM.01925-10 · DOI
- 10.3343/alm.2014.34.2.145 · DOI
- 10.1097/01.inf.0000183748.41027.a4 · DOI
- 10.3201/eid1805.111843 · DOI
- 10.1111/j.1469-0691.2009.02846.x · DOI
- 10.3201/eid1402.061567 · DOI
- 10.1128/JCM.38.3.1058-1062.2000 · DOI
- 10.1097/00006454-199010000-00005 · DOI
- 10.1017/S0950268811000240 · DOI
- 10.1128/CMR.00022-13 · DOI
- 10.1128/JCM.02056-13 · DOI
- 10.1099/0022-1317-50-8-667 · DOI
- 10.1128/JCM.01342-13 · DOI
- 10.3201/eid0805.010385 · DOI
- 10.1016/j.trstmh.2008.03.017 · DOI
- 10.1016/j.jpeds.2004.08.059 · DOI
- 10.1097/QCO.0b013e32834a8b8b · DOI
- 10.1128/JCM.02199-10 · DOI
- 10.1097/MPG.0b013e3181d29767 · DOI
- 10.1086/651706 · DOI
- 10.1016/S1473-3099(13)70200-7 · DOI
- 10.1016/j.anaerobe.2011.01.002 · DOI
- Prakash VP, McVeigh L, Williams K, Flores-Cortez EJ, Simmons D, Quilliam D, Rhode Island Department of Health Laboratory, Alexander N, Chapin K. 2014. Utility of a multiplex gastrointestinal panel to aid in epidemiological outbreak investigation of Shigella; abstr. C-1111. 114th Gen Meet Am Soc Microbiol, 17 to 20 May 2014, Boston, MA.
- 10.1001/archinte.1985.00360120079013 · DOI
- 10.1016/S0140-6736(82)91510-0 · DOI
- 10.3201/eid1410.080117 · DOI
- 10.1093/clinids/6.3.345 · DOI
- 10.1097/00006454-199512000-00003 · DOI
- 10.1097/INF.0b013e31819d646d · DOI
- 10.1097/00006454-198911000-00009 · DOI
Cited by
Sorted by citations
Liu, J., Platts-Mills, J. A., Juma, J., Kabir, F., Nkeze, J., Okoi, C., Operario, D. J., Uddin, M. J., Ahmed, S., Alonso, P. L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31529-x · Cited by 869
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609
“38%]) is consistent with other published data on different FilmArray panels and indicates there was not a significant amount of inhibition of PCR in the samples (15).”
ResultSelf-citationSyndromic Panel-Based Testing in Clinical Microbiology
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-17 · Cited by 308
“The overall specificity of the BioFire GIP was 97% (58).”
BackgroundResultMetagenomics: The Next Culture-Independent Game Changer
Forbes, J. D., Knox, N., Ronholm, J., Pagotto, F., & Reimer, A. R. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01069 · Cited by 340
“Lastly, multiplex panels are highly sensitive (90–100%) and specific (98%) (Buchan et al., 2013; Navidad et al., 2013; Onori et al., 2014; Buss et al., 2015; Harrington et al., 2015).”
BackgroundMessacar, K., Parker, S. K., Todd, J. K., & Dominguez, S. R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02264-16 · Cited by 329
New and developing diagnostic technologies for urinary tract infections
Davenport, M. T., Mach, K. E., Shortliffe, L. M. D., Banaei, N., Wang, T., & Liao, J. C. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.20 · Cited by 326
Advanced Point‐of‐Care Testing Technologies for Human Acute Respiratory Virus Detection
Zhang, Z., Ma, P., Ahmed, R., Wang, J., Akin, D., Soto, F., Liu, B., Li, P., & Demirci, U. (2021) · Advanced Materials · doi:10.1002/adma.202103646 · Cited by 231
Murphy, C., Fowler, R., Balada-llasat, J., Carroll, A., Stone, H., Akerele, O., Buchan, B., Windham, S., Hopp, A. M., Ronen, S., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-20 · Cited by 219
Self-citationSpina, A., Kerr, K. G., Cormican, M., Barbut, F., Eigentler, A., Zerva, L., Tassios, P., Popescu, G. A., Rafila, A., Eerola, E., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.04.007 · Cited by 209
“Although the published performance data substantiate the appropriateness of the chosen targets [13,14], we feel that operators of the FilmArray GI Panel should have access to such details.”
BackgroundGarcia, L., Arrowood, M., Kokoskin, E., Paltridge, G., Pillai, D., Procop, G., Ryan, N., Shimizu, R., & Visvesvara, G. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00025-17 · Cited by 208
Binnicker, M. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02103-15 · Cited by 197
“These data corroborate other published findings and underscore that the implementation of multiplex panels increases the positivity rate and the number of coinfections detected compared to conventional techniques (19, 20).”
ResultApplication of Next Generation Sequencing in Laboratory Medicine
Zhong, Y., Xu, F., Wu, J., Schubert, J. A., & Li, M. M. (2020) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.1.25 · Cited by 231
Plesiomonas shigelloides Revisited
Janda, J. M., Abbott, S. L., & McIver, C. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00103-15 · Cited by 202
“shigelloides approach 100%, although the prevalence rate for this pathogen in two of these studies was exceedingly low (233, 234, 235).”
BackgroundInfluentialFoodborne Illness Acquired in the United States—Major Pathogens, 2019
Walter, E. S., Cui, Z., Tierney, R., Griffin, P. M., Hoekstra, R. M., Payne, D. C., Rose, E. B., Devine, C. J., Namwase, A. S., Mirza, S. A., et al. (2025) · Emerging infectious diseases · doi:10.3201/eid3104.240913 · Cited by 151
Cyclospora cayetanensis and Cyclosporiasis: An Update
Almería, S., Cinar, H. N., & Dubey, J. (2019) · Microorganisms · doi:10.3390/microorganisms7090317 · Cited by 143
Cybulski, R., Bateman, A., Bourassa, L., Bryan, A., Beail, B., Matsumoto, J., Cookson, B., & Fang, F. C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy357 · Cited by 141
Rapid diagnosis of parasitic diseases: current scenario and future needs
Momčilović, S., Cantacessi, C., Arsić-Arsenijević, V. S., Otranto, D., & Otašević, S. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.04.028 · Cited by 183
Perry, J. D. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00097-16 · Cited by 173
“examined the performance of this panel for detection of a range of GI pathogens in 1,556 stool samples (192).”
BackgroundFrom the Pipeline to the Bedside: Advances and Challenges in Clinical Metagenomics
Chiang, A. D., & Dekker, J. P. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz151 · Cited by 156
Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review
Woodworth, M. H., Carpentieri, C., Sitchenko, K. L., & Kraft, C. S. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1286006 · Cited by 136
“Similarly, PCR-based multiplex panels that have been developed for rapid identification of other bacterial, viral and parasitic pathogens in infectious diarrhea have been developed compared with culture of loose/watery stool specimens.(42) While most donor screening recommendations suggest stool culture, antigen testi…”
BackgroundBànyai, K., Estes, M. K., Martella, V., & Parashar, U. D. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31128-0 · Cited by 468
Wang, R.-J., Li, J.-Q., Chen, Y.-C., Zhang, L.-X., & Xiao, L. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.08.018 · Cited by 121
Doan, T. A., Hinterwirth, A. J., Worden, L., Arzika, A. M., Maliki, R., Abdou, A., Kane, S., Zhong, L., Cummings, M. E., Sakar, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0533-0 · Cited by 132
Gronthoud, F. (2018) · Case Studies in Infectious Disease · doi:10.1007/978-3-030-27209-8 · Cited by 119
New Technologies for Detection of Enteric Parasites
Ryan, U. M., Paparini, A., & Oskam, C. L. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2017.03.005 · Cited by 136
Clostridioides difficile: diagnosis and treatments
Guery, B. P., Galpérine, T., & Barbut, F. (2019) · BMJ · doi:10.1136/bmj.l4609 · Cited by 117
Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance
Trotter, A. J., Aydin, A., Strinden, M. J., & O’Grady, J. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.03.001 · Cited by 113
Impact of Gastrointestinal Panel Implementation on Health Care Utilization and Outcomes
Axelrad, J. E., Freedberg, D. E., Whittier, S., Greendyke, W. G., Lebwohl, B., & Green, D. A. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01775-18 · Cited by 106
“5% to 100% for all targets.(4, 13) The GI panel tests for 22 analytes in stool, namely, 13 bacteria, 5 viruses, and 4 parasites, including Campylobacter jejuni, C.”
BackgroundResultFreeman, K., Mistry, H., Tsertsvadze, A., Royle, P., McCarthy, N. D., Taylor‐Phillips, S., Manuel, R. J., & Mason, J. M. (2017) · Health Technology Assessment · doi:10.3310/hta21230 · Cited by 102
“Buss et al.(20) aimed to analyse discordant samples using PCR and sequencing assays that targeted DNA sequences different from both the FilmArray panel and the comparator method.”
BackgroundMethodInfluentialHanson, K. E., & Couturier, M. R. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw494 · Cited by 99
“Recent studies have shown that 27%–33% of GI panel–positive specimens contained >1 potential pathogen [19, 28], but the clinical implications of coinfection with specific pathogen combinations have not been defined.”
BackgroundMolecular Diagnostics for Soil-Transmitted Helminths
O’Connell, E. M., & Nutman, T. B. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0266 · Cited by 108
Khodakov, D. A., Li, J., Zhang, J. X., & Zhang, D. Y. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00755-4 · Cited by 110
Norovirus Illnesses in Children and Adolescents
Shah, M. P., & Hall, A. J. (2018) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.11.004 · Cited by 109
Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease
Axelrad, J. E., Joelson, A. M., Green, P. H. R., Lawlor, G. O., Lichtiger, S., Cadwell, K., & Lebwohl, B. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0211-8 · Cited by 105
Harrington, S. M., Buchan, B. W., Doern, C. D., Fader, R., Ferraro, M. J., Pillai, D. R., Rychert, J. A., Doyle, L. J., Lainesse, A., Karchmer, T. B., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03480-14 · Cited by 98
“noted 5/24 (21%) samples false positive for Campylobacter by FilmArray that were not confirmed by alternate PCR, and Coste reported confirming 9/15 (60%) false-positive results by using an alternate PCR and EIA methods (23, 29).”
MethodPanels and syndromic testing in clinical microbiology
Dien Bard, J., & McElvania, E. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.08.001 · Cited by 92
“tionable clinical significance, including enteropathogenic E coli, which is among the most frequent positive targets when present.(41,46) Owing to the large number of tar-”
BackgroundGastli, N., Loubinoux, J., Daragon, M., Lavigne, J., Saint-Sardos, P., Pailhoriès, H., Lemarié, C., Benmansour, H., d'Humières, C., Broutin, L., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.11.014 · Cited by 90
Detection, Characterization, and Typing of Shiga Toxin-Producing Escherichia coli
Parsons, B., Zelyas, N. J., Berenger, B. M., & Chui, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00478 · Cited by 96
FilmArray™ GI panel performance for the diagnosis of acute gastroenteritis or hemorragic diarrhea
Piralla, A., Lunghi, G., Ardissino, G., Girello, A., Premoli, M., Bava, E., Arghittu, M., Colombo, M. R., Cognetto, A., Bono, P., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1018-2 · Cited by 87
“The FilmArray GI panel offers high sensitivity and specificity [14, 17, 18] and has been recently used as point-ofcare according to the syndromic approach [19].”
MethodEtiology of travellers’ diarrhea
Jiang, Z.-D., & DuPont, H. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/tax003 · Cited by 81
Giangaspero, A., & Gasser, R. B. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30789-8 · Cited by 88
Laude, A., Valot, S., Désoubeaux, G., Argy, N., Nourrisson, C., Pomares-Estran, C., Machouart, M., Govic, Y. L., Dalle, F., Botterel, F., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.019 · Cited by 92
Detection of 23 Gastrointestinal Pathogens Among Children Who Present With Diarrhea
Stockmann, C. R., Pavia, A. T., Graham, B., Vaughn, M., Crisp, R., Poritz, M. A., Thatcher, S. A., Korgenski, E. K., Barney, T., Daly, J. A., et al. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piw020 · Cited by 69
“panel was approved recently by the US Food and Drug Administration (FDA) for in vitro diagnostic use for 22 pathogens [4].”
BackgroundSelf-citationArora, H. S., Asmar, B. I., Salimnia, H., Agarwal, P., Chawla, S., & Abdel-Haq, N. (2017) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001551 · Cited by 66
Wootton, S. H., Aguilera, E., Salazar, L., Hemmert, A. C., & Hasbun, R. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0137-1 · Cited by 65
“Methods Patients admitted between November 2008 and March 2014 with community-acquired meningitis or encephalitis (fever, headache, vomiting, photophobia, stiff neck, focal neurological symptoms), CSF cell count >5 cells/ mm [3] and a negative CSF Gram stain were eligible.”
Collins, J., Shah, H. J., Weller, D., Ray, L. C., Smith, K. E., McGuire, S., Trevejo, R., Jervis, R. H., Vugia, D., Rissman, T., et al. (2022) · MMWR. Morbidity and mortality weekly report · doi:10.15585/mmwr.mm7140a2 · Cited by 67
“Molecular tests have high sensitivity for many pathogens (8) but might not indicate viable organisms.”
BackgroundInfluentialPoint-Counterpoint: Meningitis/Encephalitis Syndromic Testing in the Clinical Laboratory
Bard, J. D., & Alby, K. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00018-18 · Cited by 72
“This is most evident in cases of viral infections where standard-of-care testing as part of the initial infectious disease workup may be limited to only HSV and enterovirus PCR, missing the more esoteric viral targets (HHV-6, CMV, and HPeV) that may not be high on the list for the differential diagnosis (2, 3).”
BackgroundTorres-Miranda, D., Akselrod, H., Karsner, R., Secco, A., Silva-Cantillo, D., Siegel, M., Roberts, A. D., & Simon, G. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01394-w · Cited by 62
Impact of the BioFire FilmArray gastrointestinal panel on patient care and infection control
Machiels, J. D., Cremers, A. J. H., van Bergen-Verkuyten, M. C., Paardekoper-Strijbosch, S. J. M., Frijns, K. C. J., Wertheim, H. F. L., Rahamat-Langendoen, J. C., & Melchers, W. J. G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228596 · Cited by 55
“Discrepancy studies have been performed previously.[30] In conclusion, the BioFire FilmArray GI panel is a broad, multiplex gastrointestinal panel with a rapid turnaround time, resulting in a significant reduction of unnecessary isolation days, antibiotic therapy and prevention of additional diagnostic procedures in p…”
Rapid diagnostic tests for infectious diseases in the emergency department
Bouzid, D., Zanella, M.-C., Kernéis, S., Visseaux, B., May, L. S., Schrenzel, J., & Cattoir, V. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.02.024 · Cited by 70
“, 170 Entamoeba histolytica, Yersinia enterolitica [26]; an important consideration for 171 interpretation of negative results.”
Schuetz, A. (2019) · Seminars in diagnostic pathology · doi:10.1053/j.semdp.2019.04.012 · Cited by 60
Current knowledge on the laboratory diagnosis ofClostridium difficileinfection
Martínez-Meléndez, A., Camacho-Ortíz, A., Morfín‐Otero, R., Maldonado-Garza, H. J., Villarreal-Treviño, L., & Garza‐González, E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i9.1552 · Cited by 56
An Overview of the Molecular Methods in the Diagnosis of Gastrointestinal Infectious Diseases
Amjad, M. (2020) · International Journal of Microbiology · doi:10.1155/2020/8135724 · Cited by 70
“For the remaining 3 targets, sensitivity could not be calculated due to the low prevalence of the pathogens in the study [30].”
BackgroundChhabra, P., Gregoricus, N., Weinberg, G. A., Halasa, N., Chappell, J., Hassan, F., Selvarangan, R., Mijatovic-Rustempasic, S., Ward, M., Bowen, M., et al. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.08.012 · Cited by 55
“High rates of false positivity for norovirus detection using this platform was recently reported by others [2].”
BackgroundResultInfluentialEvaluation of the BioFire FilmArray® GastrointestinalPanel in a Midwestern Academic Hospital
Murphy, C., Fowler, R., Iwen, P., & Fey, P. (2017) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-016-2858-7 · Cited by 54
“Many studies have been performed that demonstrate the improved sensitivity of syndromic panels in the detection of GI pathogens compared with traditional stool methods [2, 12, 23].”
BackgroundSelf-citationMadison-Antenucci, S., Relich, R., Doyle, L., Espina, N., Fuller, D., Karchmer, T., Lainesse, A., Mortensen, J. E., Pancholi, P., Veros, W., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00765-16 · Cited by 54
Kellner, T., Parsons, B., Chui, L., Berenger, B., Xie, J.-L., Burnham, C., Tarr, P., Lee, B. E., Nettel-Aguirre, A., Szelewicki, J., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00205-19 · Cited by 52
“In contrast, nucleic acid amplification techniques (NAAT) can detect multiple pathogens within hours (4).”
BackgroundHitchcock, M., Gomez, C. A., & Banaei, N. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01558-17 · Cited by 50
“7) Norovirus (3) Rotavirus (1) Preceding positive ( 72 h and 72 h) 9 (9.”
BackgroundInfluentialSantos, M., Mariz, M., Tiago, I., Martins, J., Alarico, S., & Ferreira, P. C. N. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.114889 · Cited by 44
“FilmArray, developed by bioMérieux, is an integrated PCR platform that identifies the pathogen and its antibiotic susceptibility in 1 h, using a whole-sample, and is feasible to adapt to UTIs detection [38,39].”
MethodO’Shea, M. K., Clay, K. A., Craig, D. G. N., Matthews, S., Kao, R. L. C., Fletcher, T. E., Bailey, M. S., & Hutley, E. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ399 · Cited by 45
“The BioFire FilmArray is perhaps the easiest to use with minimal hands-on processing, rapid generation of results and the inclusion of an extensive and diverse spectrum of pathogenic targets [10] . High sensitivities and specificities have been reported; however, the FilmArray assay has low-throughput as only one test…”
BackgroundHannet, I., Engsbro, A. L., Pareja, J., Schneider, U. V., Lisby, J. G., Pružinec-Popović, B., Hoerauf, A. M., & Parčina, M. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03646-4 · Cited by 60
Propagation of Astrovirus VA1, a Neurotropic Human Astrovirus, in Cell Culture
Janowski, A. B., Bauer, I. K., Holtz, L. R., & Wang, D. (2017) · Journal of Virology · doi:10.1128/jvi.00740-17 · Cited by 45
Chang, L., Hsiao, C.-J., Chen, B., Liu, T.-Y., Ding, J. H., Hsu, W., Su-Ortiz, V. A., Chen, S., Su, K., Wu, H., et al. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2020-000553 · Cited by 52
HIV and diarrhoea: what is new?
Logan, C., Beadsworth, M., & Beeching, N. J. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000305 · Cited by 57
Alby, K., & Nachamkin, I. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0005-2015 · Cited by 15
“Clinical studies with the FilmArray panel have shown positivity rates in excess of 50% (94).”
BackgroundYoo, J., Park, J., Lee, H. K., Yu, J. K., Lee, D., Park, K. G., Oak, H. C., & Park, Y.-J. (2019) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0002-oa · Cited by 49
Pérot, P., Lecuit, M., & Eloit, M. (2017) · Viruses · doi:10.3390/v9010010 · Cited by 43
“9%, respectively, for the detection of MAstV 1 (but not MAstV 6 and 9), and a turnaround time of around one hour [108].”
BackgroundAdvances in Diagnostic Approaches for Viral Etiologies of Diarrhea: From the Lab to the Field
Malik, Y. S., Verma, A., Kumar, N., Touil, N., Karthik, K., Tiwari, R., Bora, D. P., Dhama, K., Ghosh, S., Hemida, M. G., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01957 · Cited by 48
Zhang, L.-X., Wang, R.-J., Zhao, G., & Li, J.-Q. (2021) · Cyclospora and Cyclosporiasis · doi:10.1016/b978-0-12-821616-3.00008-4 · Cited by 41
Axelrad, J., Joelson, A., Nobel, Y., Lawlor, G., Green, P., Lichtiger, S., & Lebwohl, B. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001097 · Cited by 40
Diagnosis of Clostridium difficile Infections in Children
Antonara, S., & Leber, A. L. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03014-15 · Cited by 49
“(2015) (49) tcdA and tcdB PCR 1556 (<1 - >65 yrs) (62%) 98.”
BackgroundSelf-citationKhairy, R. M. M., Fathy, Z. A., Mahrous, D. M., Mohamed, E. S., & Abdelrahim, S. S. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05664-6 · Cited by 50
“In the last decade, aEPEC has become more frequent in high-income and also in developing countries [36, 37].”
BackgroundFrançois, R., Yori, P., Rouhani, S., Salas, M. S., Olórtegui, M. P., Trigoso, D. R., Pisanic, N., Burga, R., Meza, R., Sánchez, G. M., et al. (2018) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006200 · Cited by 39
Performance of the QIAstat-Dx Gastrointestinal Panel for Diagnosing Infectious Gastroenteritis
Boers, S. A., Peters, C. J. A., Wessels, E., Melchers, W., & Claas, E. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01737-19 · Cited by 38
“coli pathotypes detected were detected as coinfection or colonization with at least one (other) established enteropathogen, which is consistent with results from previous studies (28, 30, 31) and which complicates studies toward the clinical relevance and pathogenicity of E.”
ResultPotgieter, N., Heine, L., Kabue, J. P., Ledwaba, S. E., Zitha, T., Mudau, L. S., Becker, P., Traoré, A. N., & Barnard, T. G. (2023) · Pathogens · doi:10.3390/pathogens12020315 · Cited by 46
“Further complicating the interpretation of results obtained by utilisation of the BioFire® Film Array® GI Panel (BioFire Diagnostics, Salt Lake City, UT, USA) is that several enteric pathogens are shed over a prolonged period by patients who have already recovered from an episode of diarrhoea and are asymptomatic at t…”
ResultThe GenMark ePlex®: another weapon in the syndromic arsenal for infection diagnosis.
Schmitz, J. E., & Tang, Y.-W. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0258 · Cited by 37
Gonzalez, M. D., Langley, L., Buchan, B., Faron, M., Maier, M., Templeton, K., Walker, K., Popowitch, E., Miller, M. B., Rao, A., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02361-15 · Cited by 37
“Two recent studies (14, 15) evaluated the FilmArray GI panel, using a CDC-based assay as the reference method for norovirus detection (31), and reported sensitivities of 91.”
MethodUse of a multiplex DNA extraction PCR in the identification of pathogens in travelers’ diarrhea
Connor, B. A., Rogova, M., & Whyte, O. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/tax087 · Cited by 44
Teh, R., Tee, W. D., Tan, E. X. X., Fan, K. H., Koh, C. J., Tambyah, P. A., Oon, J. E. L., Tee, N. W. S., Soh, A. Y. S., & Siah, K. T. H. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15581 · Cited by 42
Beganovic, M., McCreary, E. K., Mahoney, M. V. G., Dionne, B., Green, D. A., & Timbrook, T. T. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.026450 · Cited by 34
“1%, GI panels can be instrumental in deescalation efforts for ASPs (73).”
BackgroundGallardo, P., Izquierdo, M., Vidal, R. M., Chamorro-Veloso, N., Rossello-Mora, R. A., O’Ryan, M., & Farfán, M. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00424 · Cited by 40
“Implementation of molecular techniques allowing simultaneous detection of multiple enteric pathogens, including DEC pathotypes, have shown that the prevalence of these pathotypes in diarrheal infections is higher than previously thought (Buss et al., 2015; Farfán et al., 2016).”
BackgroundFreeman, K., Tsertsvadze, A., Taylor‐Phillips, S., McCarthy, N. D., Mistry, H., Manuel, R. J., & Mason, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173196 · Cited by 38
Multani, A., Allard, L. S., Wangjam, T., Sica, R. A., Epstein, D. J., Rezvani, A. R., & Ho, D. Y. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000634 · Cited by 35
“However, clinicians should be familiar with the multiplex syndromic PCRs used at their institution because some of these assays may not detect all adenovirus serotypes known to cause disease in HCT recipients.(35-38) In the setting of high clinical suspicion for adenoviral disease, clinicians may hesitate to administe…”
BackgroundPaulos, S., Saugar, J. M., de Lucio, A., Fuentes, I., Mateo, M., & Carmena, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215068 · Cited by 43
Calderaro, A., Martinelli, M., Buttrini, M., Montecchini, S., Covan, S., Rossi, S., Ferraglia, F., Montagna, P., Pinardi, F., Larini, S., et al. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.04.007 · Cited by 34
Beyond the Gastrointestinal Tract: The Emerging and Diverse Tissue Tropisms of Astroviruses
Janowski, A. B. (2021) · Viruses · doi:10.3390/v13050732 · Cited by 35
Zhang, L. T., Westblade, L. F., Iqbal, F., Taylor, M. R., Chung, A. P., Satlin, M. J., Magruder, M. L., Edusei, E., Albakry, S., Botticelli, B., et al. (2021) · Clinical Transplantation · doi:10.1111/ctr.14260 · Cited by 35
Advances in Cyclosporiasis Diagnosis and Therapeutic Intervention
Li, J.-Q., Cui, Z., Qi, M., & Zhang, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00043 · Cited by 32
Integrated LAMP and immunoassay platform for diarrheal disease detection
Phaneuf, C., Mangadu, B., Tran, H. M., Light, Y. K., Sinha, A., Charbonier, F. W., Eckles, T. P., Singh, A. K., & Koh, C.-Y. (2018) · Biosensors & bioelectronics · doi:10.1016/j.bios.2018.08.005 · Cited by 32
Knabl, L., Grutsch, I., & Orth‐Höller, D. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2517-4 · Cited by 33
Foster, M. A., Iqbal, J., Zhang, C., McHenry, R. E., Cleveland, B. E., Romero, Y., Fonnesbeck, C., Payne, D. C., Chappell, J. D., Halasa, N., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.07.016 · Cited by 32
“As new multipanel systems for DEC detection become available, more accurate epidemiological data on DEC in the United States will be reported (Buss et al., 2015).”
Leli, C., di Matteo, L., Gotta, F., Vay, D., Cavallo, V., Mazzeo, R., Busso, S., Carrabba, L., & Rocchetti, A. (2019) · Infectious Diseases · doi:10.1080/23744235.2019.1688861 · Cited by 31
“[10], nevertheless, in that study, the 86.”
BackgroundResultIs Follow-Up Testing with the FilmArray Gastrointestinal Multiplex PCR Panel Necessary?
Park, S., Hitchcock, M. M., Gómez, C. A., & Banaei, N. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02354-16 · Cited by 38
“The FilmArray gastrointestinal (GI) panel (BioFire Diagnostics, Salt Lake City, UT) is a novel sample-to-answer, on-demand, multiplex, real-time PCR assay for the syndromic diagnosis of infectious gastroenteritis (1).”
BackgroundLiesman, R. M., & Binnicker, M. J. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000276 · Cited by 34
Laszkowska, M., Kim, J., Faye, A. S., Joelson, A. M., Ingram, M. A., Truong, H., Silver, E. R., May, B. L., Greendyke, W. G., Zucker, J. E., et al. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06760-y · Cited by 39
Bridging Systemic Immunity with Gastrointestinal Immune Responses via Oil‐in‐Polymer Capsules
Xia, Y., Wu, J., Du, Y., Miao, C., Su, Z. G., & Ma, G. (2018) · Advanced Materials · doi:10.1002/adma.201801067 · Cited by 34
Future potential of metagenomics in microbiology laboratories
Schuele, L., Cassidy, H., Peker, N., Rossen, J. W. A., & Couto, N. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.2001329 · Cited by 35
Riddle, M. S., Savarino, S. J., & Sanders, J. W. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0200 · Cited by 38
Chao, A. W., Bhatti, M. M., DuPont, H. L., Nataro, J. P., Carlin, L. G., & Okhuysen, P. C. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.08.004 · Cited by 31
“…(NAATs) that can simultaneously detect the presence of multiple enteropathogens in stools of patients in a cost efficient manner is increasing our ability to define the epidemiology, clinical implications and outcomes of infectious diarrhea in pediatric and adult populations(Buss et al., 2015).”
BackgroundMoon, R. C., Bleak, T. C., Rosenthal, N. A., Couturier, B. A., Hemmert, R. B., Timbrook, T. T., Brown, H., & Fang, F. C. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01628-22 · Cited by 22
“We hypothesized that the outcomes would be different for smaller panels (PCR , 12) and larger panels (PCR $ 12) since one of the benefits of multiplex PCR test is testing simultaneously for many different pathogens (23).”
Background
Metadata
- Authors
- Buss, S. N., Leber, A., Chapin, K., Fey, P. D., Bankowski, M. J., Jones, M. K., Rogatcheva, M., Kanack, K. J., & Bourzac, K. M.
- Affiliations
- University of Nebraska Medical Center (US)
- Nationwide Children's Hospital (US)
- Lifespan (US)
- University of Hawaiʻi at Mānoa (US)
- BioFire Diagnostics (United States) (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2015-03
- Volume
- 53
- Issue
- 3
- Pages
- 915-925
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC4390666
- OpenAlex
- W2169792847
- Cited by
- 554
- References
- 0
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 42 · 2023: 62 · 2022: 43 · 2021: 51 · 2020: 61 · 2019: 41 · 2018: 58 · 2017: 48 · 2016: 39 · 2015: 18
- FWCI
- 42.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- BioFire Diagnostics
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI104593, R01AI089489)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Keywords
- infectious gastroenteritis, enteric pathogens, multiplex PCR, sensitivity and specificity, diarrheagenic Escherichia coli, norovirus, rotavirus, sapovirus, Cryptosporidium, Giardia lamblia, Shiga toxin-producing Escherichia coli, rapid molecular diagnostics
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Bacteria, Child, Child, Preschool, Feces, Female, Gastroenteritis, Humans, Infant, Infant, Newborn, Male, Microbiological Techniques, Middle Aged, Parasites, Prospective Studies, Sensitivity and Specificity, Time Factors, Viruses, Molecular Diagnostic Techniques, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review